Internal Medicine, Endocrinology, Diabetes, & Metabolism · Midlothian, TX
NPI
1669777850
Since 2011
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4431 E Highway 287
Midlothian, TX, 76065
Phone (469) 800-9860
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
1,209 services
Medicare patients, 2024
235
Average age 73
Drug cost, 2024
$2.7M
4,242 prescriptions
Company payments, 2025
$2,726
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria Renela G Suller was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 270 times for 204 patients. In total Maria Renela G Suller billed 1,209 services in 14 codes, and Medicare paid $40K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-12.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 270 | 204 | $11.00 | $2,969 |
| 83036 Blood Count | Office | 215 | 128 | $9.42 | $2,026 |
| 36415 Venipuncture Blood Collection | Office | 212 | 160 | $8.54 | $1,810 |
| 95251 Test - Miscellaneous | Office | 197 | 95 | $24.52 | $4,830 |
| 99214 Office E&M - Established | Office | 176 | 139 | $76.22 | $13K |
| 99215 Office E&M - Established | Office | 110 | 83 | $113.50 | $12K |
By year: 2022 $70K for 1,461 services; 2023 $46K for 1,121 services; 2024 $40K for 1,209 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 215 | 128 | $9.42 | $2,026 |
| 36415 Venipuncture Blood Collection | 212 | 160 | $8.54 | $1,810 |
Medicare prescription drug claims, 2024
In 2024, the drug Maria Renela G Suller prescribed most often to Medicare patients was Pioglitazone Hcl, with 598 prescriptions and refills. In total Maria Renela G Suller wrote 4,242 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pioglitazone Hcl Generic | 598 | 1,699 | 177 | $8,723 |
| Ozempic Semaglutide | 493 | 835 | 121 | $800K |
| Levothyroxine Sodium Generic | 486 | 1,321 | 139 | $4,517 |
| Mounjaro Tirzepatide | 243 | 341 | 51 | $350K |
| Metformin Hcl Er Metformin Hcl | 146 | 379 | 47 | $1,488 |
| Tresiba Flextouch U-100 Insulin Degludec | 125 | 278 | 53 | $178K |
| Farxiga Dapagliflozin Propanediol | 115 | 221 | 29 | $122K |
| Glimepiride Generic | 96 | 230 | 31 | $801 |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 95 | 209 | 25 | $116K |
| Trulicity Dulaglutide | 95 | 146 | 26 | $141K |
| Jardiance Empagliflozin | 94 | 216 | 28 | $123K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 89 | 254 | 32 | $145K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 77 | 142 | 47 | $11K |
| Atorvastatin Calcium Generic | 77 | 217 | 25 | $948 |
| Methimazole Generic | 77 | 223 | 26 | $722 |
Brand drugs: 2,143 claims; generic drugs: 1,676 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria Renela G Suller $2,726 ($2,726 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbott Laboratories with $849.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 33 | $849 |
| CeQur Corporation | 1 | $405 |
| Sequel Med Tech, LLC | 16 | $339 |
| Novo Nordisk Inc NVO | 18 | $299 |
| Lilly USA, LLC LLY | 8 | $137 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $117 |
| Dexcom, Inc. DXCM | 4 | $117 |
| Insulet Corporation PODD | 4 | $89.64 |
| Beta Bionics, Inc. BBNX | 6 | $80.11 |
| Xeris Pharmaceuticals, Inc. | 4 | $69.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.